Quotes: MENA   Enter Symbol: NewsLetter: Search: advanced

Promethera(R)Biosciences welcomes Frank Hazevoets as chief financial officer  Join our daily free Newsletter

MENAFN Press - 13/05/2014
No. of Ratings : 0
Add to Mixx!



(MENAFN Press) Promethera(R) Biosciences, an innovative orphan drug therapy company that develops stem cell therapies for the treatment of liver diseases, today announces that Frank Hazevoets has joined the company to lead its finance and administration team. Frank joined Promethera Biosciences SA on May 1, 2014 as chief financial officer (CFO). He will be based at the head office in Mont-Saint-Guibert, Belgium.

Frank Hazevoets is a highly experienced senior financial executive with over twenty five years international business experience. He trained at the Catholic University of Leuven (KUL) in Belgium as a commercial engineer and also obtained a masters degree in Artificial Intelligence and Cognitive Science. He has worked in leading positions in corporate finance and investment banking, strategy and business development. During his six years as CFO at Tigenix, he supported the company in its funding and growth strategy and helped them to obtain the first European marketing authorization for cell-based medicinal products in Europe.

"We are delighted that Frank is joining Promethera Biosciences as CFO," said Eric Halioua, chief executive officer. "He is going to play a key role in assisting our future development. Frank Hazevoets has the experience and expertise to strengthen the management team and to prepare the next strategic options at Promethera Biosciences. He will build the finance department to further support the future growth of Promethera(R)."

"I am really looking forward to working with the experienced team at Promethera and to sharing my expertise with them," said Frank Hazevoets, chief financial officer of Promethera Biosciences. "This company has the potential to become one of the leading orphan drug companies in the world. Many patients will benefit from their lead in developing and commercializing innovative cell and orphan therapy products based on propriary technologies."


About Promethera Biosciences:

Promethera Biosciences is a pharmaceutical company that develops innovative therapies for the treatment of orphan liver diseases. It is currently developing two products based on human liver progenitor cells:

Promethera(R) HepaStem is a cell therapy product based on the use of allogeneic stem cells isolated from healthy adult human livers (Heterologous Human Adult Liver Progenitor Cells, HHALPC). These cells can be used to treat a wide variety of liver diseases, from rare inborn metabolic diseases (which can be classified as 'orphan diseases' and mainly affecting children), to acquired deficiencies affecting adults, such as acute-on chronic liver diseases or liver fibrosis. HepaStem is currently tested in phase I/II clinical trial in Europe and Israel for the treatment of two orphan indications.

Promethera(R) H2Screen and H3Screen is a non-therapeutic in vitro product, based on a recently discovered and patented liver progenitor cell type, isolated from healthy adult human livers. This novel biotechnology tool is designed for early preclinical pharmaco-toxicological evaluation of drug candidates and new chemical entities.

Promethera Biosciences is a spin-off of the Universite Catholique de Louvain (UCL), founded in 2009. The company emerged from the lab of Professor Etienne Sokal, a leading expert in pediatric liver disease and cell. Promethera Biosciences is located in Mont-Saint-Guibert (Belgium).

Since its creation in 2009, Promethera Biosciences has raised EUR 34 million in two financial rounds, in capital, grants and loans from the Walloon Region. The main investors are Vesalius Biocapital, Mitsui Global Investment, BI Venture Fund, Shire and SRIW.

Promethera Biosciences has 47 employees led by an experienced management team.

For more information, please visit http://www.promethera.com


About Promethera(R)
Promethera(R)

 


MENAFN Press




  MENA News Headlines
 Jul 25 2016 - Saudi's PetroRabigh net profit falls 80 pct in Q2MENAFN
(MENAFN) Saudi Arabia's Rabigh Refining and Petrochemical Co (PetroRabigh) said it has experienced a 79.6 percent drop in net profit during the second quarter.The company, a joint venture between ...

 Jul 25 2016 - Abu Dhabi hosts strategic investments meetingMENAFN
(MENAFN) Pooling knowledge and resources from within the oil and gas industry is vital to energy sector progress, said senior officials and world representatives at a recent gathering in Abu Dhabi.In ...

 Jul 25 2016 - 390m revenues of Vodafone Egypt in Q4 of FY 2015/2016Daily News Egypt
(MENAFN - Daily News Egypt) Vodafone Egypt achieved an 11.2% growth in its revenues during the fourth quarter (Q4) of fiscal year (FY) 2015/2016 which ended in March. According to the data from the ...

 Jul 25 2016 - Knesset members to visit Saudi, recognised relations with Israel come to the lightDaily News Egypt
(MENAFN - Daily News Egypt) Arab-Israeli member of the Knesset Issawi Frej told Israeli state media on Sunday that preparations are ongoing for a visit of opposition members in the Israeli parliament ...

 Jul 25 2016 - Environment minister meets with African counterparts to prepare for COP22Daily News Egypt
(MENAFN - Daily News Egypt) Minister of Environment Khaled Fahmy held a meeting with his counterparts from Gabon, Niger, and Namibia on Sunday in Cairo, in his capacity as the president of the ...

 Jul 25 2016 - Has the public's initial post-Brexit denial passed?Daily News Egypt
(MENAFN - Daily News Egypt) Britain's decision to leave the EU fueled a rise in xenophobia and fears about the future. A month after the bombshell, DW talks to remain voters and EU nationals in the ...

 Jul 25 2016 - Internet market attracts 200,000 new customers in April 2016Daily News Egypt
(MENAFN - Daily News Egypt) A report by the Ministry of Communications and Information Technology has shown a slight decline of 0.12% in the number of mobile service subscribers in April, compared to ...

 Jul 25 2016 - Unified sermon is in the best interest of society: Ministry of Religious EndowmentsDaily News Egypt
(MENAFN - Daily News Egypt) The decision to unify Friday prayers by giving preachers written sermons is in the best interests of society, Minister of Religious Endowments Mohamed Mokhtar Gomaa said ...

 Jul 25 2016 - DPI acquires 33.3% of B.TECH, worth $35mDaily News Egypt
(MENAFN - Daily News Egypt) The Financial Times reported on Sunday that private equity firm DPI will acquire 33.3% of household appliances retailer B.TECHa deal worth $35m. According to a previous ...

 Jul 25 2016 - Egyptian renewable energy disinvestment over price and arbitration disagreementsDaily News Egypt
(MENAFN - Daily News Egypt) Italy's Enel Green Power has exited the renewable energy market in Egypt and is seeking compensation for investments it has already injected, according to Al-Borsa ...

more...


 





Google

Easy Forex

 
 

Middle East North Africa - Financial Network

MENAFN News Market Data Countries Tools Section  
 

Middle East North Africa - Financial Network
Arabic MENAFN

Main News
News By Industry
News By Country

Islamic Finance News
Private Equity News

How-To Guides
Technology Section

Travel Section

Search News

Market Indices
Quotes & Charts

Global Indices
Arab Indices

Commodoties

Oil & Energy

Currencies Cross Rates
Currencies Updates
Currency Converter

USA Stocks
Arab Stocks
 

Algeria 
Bahrain 
Egypt 
Iraq
Jordan 
Kuwait 
Lebanon
Morocco 
Oman 
Palestine
Qatar 
Saudi Arabia 
Syria
Tunisia 
UAE 
Yemen

Weather
Economic Calendar
Financial Glossary


Financial Calculators

RSS Feeds [XML]

Corporate Monitor

Events

Real Estate
Submit Your Property

Arab Research
Buy a Research

Press Releases
Submit your PR

Join Newsletters


 
© 2014 menafn.com All Rights Reserved.  Terms of Service | Privacy Policy | Contact Us | Advertise | About MENAFN | Career Opportunities | Feedback | Help